0.409
0.01 (2.07%)
| Penutupan Terdahulu | 0.400 |
| Buka | 0.400 |
| Jumlah Dagangan | 120,712 |
| Purata Dagangan (3B) | 756,350 |
| Modal Pasaran | 19,821,934 |
| Harga / Jualan (P/S) | 0.500 |
| Harga / Buku (P/B) | 2.07 |
| Julat 52 Minggu |
| Margin Keuntungan | 9.19% |
| Margin Operasi (TTM) | 9.24% |
| EPS Cair (TTM) | 0.170 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 58.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 232.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 43.88% |
| Nisbah Semasa (MRQ) | 2.46 |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Distribution (US) | Bercampur | Menaik |
| Medical Distribution (Global) | Bercampur | Menaik | |
| Stok | Cellyan Biotechnology Co., Ltd | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.63 |
|
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market. |
|
| Sektor | Healthcare |
| Industri | Medical Distribution |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 68.01% |
| % Dimiliki oleh Institusi | 0.47% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |